Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
ASND
Fundamentals

Ascendis Pharma A/s

ASND

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

173.92M
▲116.08M▲200.72%
3 Months Change

Assets

1.18B
▲85.71M▲7.84%
3 Months Change

Liabilities

1.29B
▲94.10M▲7.90%
3 Months Change

Free Cash Flow

-101.78M
▲46.35M▲31.29%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2024-02-07
Form 20-F
ID: 0000950170-24-012212
2023-02-16
Form 20-F
ID: 0000950170-23-003068
2022-03-02
Form 20-F
ID: 0001193125-22-062998
2021-03-10
Form 20-F
ID: 0001193125-21-076349
2020-04-03
Form 20-F
ID: 0001193125-20-096870
2019-04-03
Form 20-F
ID: 0001193125-19-096759
2018-03-28
Form 20-F
ID: 0001193125-18-099514
2017-03-22
Form 20-F
ID: 0001193125-17-092073
2016-04-15
Form 20-F
ID: 0001193125-16-543253
2015-03-26
Form 20-F
ID: 0001193125-15-107137